WallStreetZenWallStreetZen

NASDAQ: TNXP
Tonix Pharmaceuticals Holding Corp Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their TNXP stock forecasts and price targets.

Forecast return on equity

Is TNXP forecast to generate an efficient return?

Company
-1.56%
Industry
75.98%
Market
342.02%
TNXP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is TNXP forecast to generate an efficient return on assets?

Company
-1.43%
Industry
22.59%
TNXP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

TNXP earnings per share forecast

What is TNXP's earnings per share in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
-$13.39-104.8%
Avg 2 year Forecast
-$8.78-103.15%
Avg 3 year Forecast
-$0.31-100.11%

TNXP revenue forecast

What is TNXP's revenue in the next 3 years based on estimates from 5 analysts?

Avg 1 year Forecast
$11.6M+12.51%
Avg 2 year Forecast
$119.8M+1,062.73%
Avg 3 year Forecast
$134.1M+1,202.36%
TNXP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TNXP revenue growth forecast

How is TNXP forecast to perform vs Biotechnology companies and vs the US market?

Company
194.24%
Industry
286.29%
Market
58.59%
TNXP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TNXP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TNXP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
TNXP$19.64N/AN/A
HUMA$1.23$8.67+604.63%Strong Buy
MIST$2.68$4.00+49.25%Strong Buy
TNYA$1.41$7.00+396.45%Strong Buy
MDWD$17.68$36.00+103.62%Buy
View Top Biotech Stocks

Tonix Pharmaceuticals Holding Stock Forecast FAQ

What is TNXP's earnings growth forecast for 2025-2027?

(NASDAQ: TNXP) Tonix Pharmaceuticals Holding's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 73.4%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 104.81%.

Tonix Pharmaceuticals Holding's earnings in 2025 is -$99,219,000.On average, 5 Wall Street analysts forecast TNXP's earnings for 2025 to be -$157,718,516, with the lowest TNXP earnings forecast at -$172,538,117, and the highest TNXP earnings forecast at -$128,970,800. On average, 4 Wall Street analysts forecast TNXP's earnings for 2026 to be -$103,423,947, with the lowest TNXP earnings forecast at -$112,409,449, and the highest TNXP earnings forecast at -$92,492,961.

In 2027, TNXP is forecast to generate -$3,603,622 in earnings, with the lowest earnings forecast at -$3,462,303 and the highest earnings forecast at -$3,709,611.

If you're new to stock investing, here's how to buy Tonix Pharmaceuticals Holding stock.

What is TNXP's revenue growth forecast for 2025-2027?

(NASDAQ: TNXP) Tonix Pharmaceuticals Holding's forecast annual revenue growth rate of 194.24% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 286.29%, and while it is forecast to beat the US market's average forecast revenue growth rate of 58.59%.

Tonix Pharmaceuticals Holding's revenue in 2025 is $10,299,000.On average, 5 Wall Street analysts forecast TNXP's revenue for 2025 to be $136,454,792, with the lowest TNXP revenue forecast at $100,406,797, and the highest TNXP revenue forecast at $183,984,916. On average, 4 Wall Street analysts forecast TNXP's revenue for 2026 to be $1,410,240,905, with the lowest TNXP revenue forecast at $361,233,649, and the highest TNXP revenue forecast at $2,516,411,495.

In 2027, TNXP is forecast to generate $1,579,587,578 in revenue, with the lowest revenue forecast at $1,517,642,968 and the highest revenue forecast at $1,626,104,919.

What is TNXP's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: TNXP) forecast ROA is -1.43%, which is lower than the forecast US Biotechnology industry average of 22.59%.

What is TNXP's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: TNXP) Tonix Pharmaceuticals Holding's current Earnings Per Share (EPS) is $279.11. On average, analysts forecast that TNXP's EPS will be -$13.39 for 2025, with the lowest EPS forecast at -$14.65, and the highest EPS forecast at -$10.95. On average, analysts forecast that TNXP's EPS will be -$8.78 for 2026, with the lowest EPS forecast at -$9.55, and the highest EPS forecast at -$7.85. In 2027, TNXP's EPS is forecast to hit -$0.31 (min: -$0.29, max: -$0.32).

What is TNXP's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: TNXP) forecast ROE is -1.56%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.